EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.USD700,000,000 5.250 per cent. notes due 2024 have become effective (1521415)
December 28 2022 - 2:30AM
UK Regulatory
EVRAZ plc (EVR) EVRAZ plc announces that the Appointment and the
Amendments adopted as part of the Consent Solicitation for its
outstanding U.S.USD700,000,000 5.250 per cent. notes due 2024 have
become effective 28-Dec-2022 / 10:30 MSK Dissemination of a
Regulatory Announcement, transmitted by EQS Group. The issuer is
solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO
ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS
UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE
CONSENT SOLICITATION MEMORANDUM.
EVRAZ plc announces that the Appointment and the Amendments
adopted as part of the Consent Solicitation for its outstanding
U.S.USD700,000,000 5.250 per cent. notes due 2024 have become
effective
London, 28 December 2022 - on 15 November 2022, EVRAZ plc (the
"Issuer") announced a consent solicitation in relation to the
outstanding U.S.USD700,000,000 5.250 per cent. notes due 2024
issued by the Issuer (Regulation S Notes: Common Coder 184344327 /
ISIN XS1843443273; Rule 144A Notes: Common Code 111730776 / ISIN
US30052KAA79/ CUSIP 30052KAA7 ) (the "Notes") on the terms and
subject to the conditions set forth in the consent solicitation
memorandum dated 15 November 2022 (the "Consent Solicitation
Memorandum"). Capitalised terms used, but not defined herein, shall
have the meanings given to them in the Consent Solicitation
Memorandum.
The Issuer notifies that, on 23 December 2022, (i) the Issuer
and the New Trustee entered into the Deed of Appointment to
effectuate the Appointment; and (ii) the Issuer and the New Trustee
entered into the Supplemental Trust Deed to effectuate the
Amendments. Accordingly, the Appointment and the Amendments have
become effective and binding on all Noteholders with effect from
that date.
The Issuer extends its gratitude for the support and cooperation
demonstrated by investors which has been reflected in the
successful results of the Consent Solicitation.
Questions and requests for assistance in connection with the
Consent Solicitation should be directed to the Information and
Tabulation Agent:
Limited liability company "Legal Capital Investor Services"
Address: 10 Krivokolenny lane, bldg. 6, Moscow 101000,
Russia
Email: evraz@lcpis.ru
Phone: +7 495 122 05 17
Website: www.lcpis.ru
###
For further information:
Investor Relations
+7 495 232 1370
ir@evraz.com
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00B71N6K86, XS1533915721, XS1843443273,
Category Code: MSCL
TIDM: EVR
LEI Code: 5493005B7DAN39RXLK23
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 211143
EQS News ID: 1521415
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1521415&application_name=news
(END) Dow Jones Newswires
December 28, 2022 02:30 ET (07:30 GMT)
Evraz (LSE:EVR)
Historical Stock Chart
From Nov 2024 to Dec 2024
Evraz (LSE:EVR)
Historical Stock Chart
From Dec 2023 to Dec 2024
